Author: Hongyi Chen; Zhicheng Zhang; Li Wang; Zhihua Huang; Fanghua Gong; Xiaodong Li; Yahong Chen; Jinzi J. WU
Title: First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients Document date: 2020_3_24
ID: b3y9zxjr_29_1
Snippet: ent received the last dose of danoprevir boosted by ritonavir. ï¬ On February 26, CT scans showed the lesions in tongue-like segment of the lung were ↓ indicates the value is lower than the minimum reference value. ↑ indicates the value is higher than the maximum reference value. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
Document: ent received the last dose of danoprevir boosted by ritonavir. ï¬ On February 26, CT scans showed the lesions in tongue-like segment of the lung were ↓ indicates the value is lower than the minimum reference value. ↑ indicates the value is higher than the maximum reference value. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- cc ND international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc ND international license and reference value: 1, 2
- CT scan and international license: 1, 2, 3, 4, 5, 6, 7, 8
- CT scan and reference value: 1, 2, 3, 4
- international license and reference value: 1, 2
- maximum reference value and reference value: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date